| 1. |
- Alessandro, B., et al.
(författare)
-
Vector boson scattering : Recent experimental and theory developments
- 2018
-
Ingår i: Reviews in Physics. - : Elsevier BV. - 2405-4283. ; 3, s. 44-63
-
Tidskriftsartikel (refereegranskat)abstract
- This document summarises the talks and discussions happened during the VBSCan Split17 workshop, the first general meeting of the VBSCan COST Action network. This collaboration is aiming at a consistent and coordinated study of vector-boson scattering from the phenomenological and experimental point of view, for the best exploitation of the data that will be delivered by existing and future particle colliders.
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Hella, M. M., et al.
(författare)
-
2 GHz controllable power amplifier in standard CMOS process for short-range wireless applications
- 2002
-
Ingår i: IEE Proceedings - Circuits Devices and Systems. - : Institution of Engineering and Technology (IET). - 1350-2409 .- 1359-7000. ; 149:06-maj, s. 363-368
-
Tidskriftsartikel (refereegranskat)abstract
- The authors present the design and implementation of a broadband radiofrequency power amplifier in a standard CMOS technology for short-range wireless applications. The amplifier is implemented in a standard 0.35 mum triple metal CMOS process. The amplifier is capable of delivering a maximum output power of 16.6 dBm at 1.91 GHz, and of 16 dBm at 2 GHz using a 3.3 V supply with an overall measured power added efficiency (PAE) of 33%. The power amplifier employs a class AB output stage, which represents a compromise between efficiency and linearity. The level of output power can be controlled in 2 dB Steps using a number of parallel semi-cascode stages.
|
|
| 6. |
|
|
| 7. |
- Hultin, Hella, et al.
(författare)
-
Association of parathyroid adenoma and pregnancy with preeclampsia
- 2009
-
Ingår i: Journal of Clinical Endocrinology and Metabolism. - : The Endocrine Society. - 0021-972X .- 1945-7197. ; 94:9, s. 3394-3399
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: Case reports have described associations between calcium metabolism disturbances and primary hyperparathyroidism with preeclampsia, suggesting parathyroid involvement in preeclampsia etiology. This study examines whether parathyroid adenoma, the main cause of hyperparathyroidism, diagnosed and treated before pregnancy is associated with preeclampsia. DESIGN: We conducted a register-based study to assess the association between parathyroid adenoma and subsequent preeclampsia. SETTING: Births among Sweden's general population were studied. POPULATION: The study population included 52 women with a diagnosis of parathyroid adenoma and 519 without, all of whom had a subsequent singleton pregnancy between 1973 and 1997. METHODS: We performed a conditional logistic regression investigating the association of parathyroid adenoma with subsequent preeclampsia in the first singleton pregnancy with adjustment for potential confounding factors. MAIN OUTCOME MEASURE: The main outcome was a diagnosis of preeclampsia that does not include women with prior chronic hypertension. To ensure that treatment of parathyroid adenoma was completed before pregnancy, those with a diagnosis of parathyroid adenoma made less than 2 yr before delivery (and the matched comparison women) were excluded. RESULTS: Statistically, parathyroid adenoma prior to delivery is significantly (P < 0.001) associated with preeclampsia, producing an adjusted odds ratio of 6.89 (95% confidence interval, 2.30, 20.58). CONCLUSION: A history of parathyroid adenoma should be viewed as a risk for preeclampsia.
|
|
| 8. |
|
|
